Clinical Trial Update: A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis [Phase 1, Phase 2]

View source ↗

Summary

The study 'A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis' is a Phase 1/2 trial currently recruiting to evaluate XTMAB-16 in pulmonary sarcoidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis

Drugs mentioned

• XTMAB-16

Snippet

Sponsor: Xentria, Inc. | Conditions: Pulmonary Sarcoidosis | Phase 1, Phase 2 | Status: RECRUITING